MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$77,083K
Cash and cash
equivalents
$41,499K
Prepaid expenses and
other current assets
$1,863K
Total property and
equipment
$8,207K
Total current assets
$120,445K
Property and equipment,
net
$4,889K
Operating lease
right-of-use assets
$2,527K
Other assets
$1,653K
Restricted cash
$203K
Less accumulated
depreciation
$3,318K
Total assets
$129,717K
Total liabilities and
stockholders' equity
$129,717K
Total stockholders'
equity
$112,516K
Total liabilities
$17,201K
Accumulated deficit
-$274,881K
Additional paid-in capital
$387,255K
Total current
liabilities
$15,664K
Operating lease
liabilities, non-current
$1,537K
Accumulated other
comprehensive income
$111K
Common stock, 0.001 par
value 500,000,000...
$31K
Accrued expenses and
other current...
$12,215K
Accounts payable
$2,277K
Operating lease
liabilities, current
$1,172K
Back
Back
Balance Sheet
source: myfinsight.com
Acrivon Therapeutics, Inc. (ACRV)
Acrivon Therapeutics, Inc. (ACRV)